Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.93 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.36 |
| ▸ | CDC25B | P30305 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29662067 | 1.00 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL8672325 | 1.00 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL20928 | 1.00 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| Hydrochloric Acid SCHEMBL28927283 | 0.96 | LMNA (0.87) | LMNABLMPTPN1MEN1CYP3A4 | |
| Squalane SCHEMBL15449 | 0.96 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL29030039 | 0.96 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| Squalane SCHEMBL4708649 | 0.96 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL2985725 | 0.96 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11601594 | 0.96 | LMNA (0.87) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL30230194 | 0.96 | LMNA (1.00) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7300593-A | — | — | None | — | — | JP | disclosed |
| EP-4577593-B1 | ELASTOMER WITH C-O-SI LINKAGES BETWEEN POLYESTER BACKBONE AND CROSSLINKER | DOW SILICONES CORP (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12441846-B2 | Elastomer with C—O—Si linkages between polyester backbone and crosslinker | DOW SILICONES CORPORATION (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250263521-A1 | ELASTOMER WITH C-O-Si LINKAGES BETWEEN POLYESTER BACKBONE AND CROSSLINKER | DOW SILICONES CORPORATION | 2025-08-21 | — | — | US | disclosed |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2025-06-19 | — | — | US | disclosed |
| EP-4387582-A1 | METHOD FOR INHIBITING CRYSTALLISATION | Biosynthis (FR) | 2024-06-26 | — | — | EP | disclosed |
| CN-117940101-A | Method for inhibiting crystallization | 碧昂赛恩斯公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023020979-A1 | METHOD FOR INHIBITING CRYSTALLISATION | BIOSYNTHIS (FR) | 2023-02-23 | — | — | WO | disclosed |
| US-10894754-B2 | Stabilization and hydrogenation methods for microbial-derived olefins | Amyris, Inc. (US) | 2021-01-19 | — | — | US | disclosed |
| EP-2935177-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE | DSM IP ASSETS BV (NL) | 2019-07-24 | — | — | EP | disclosed |
| US-20170283346-A1 | STABILIZATION AND HYDROGENATION METHODS FOR MICROBIAL-DERIVED OLEFINS | EUAGORE, LLC | 2017-10-05 | — | — | US | disclosed |
| EP-2414311-B1 | STABILIZATION AND HYDROGENATION METHODS FOR MICROBIAL-DERIVED OLEFINS | AMYRIS INC (US) | 2017-06-07 | — | — | EP | disclosed |
| US-9611189-B2 | Stabilization and hydrogenation methods for microbial-derived olefins | Amyris, Inc. (US) | 2017-04-04 | — | — | US | disclosed |
| US-20130310617-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | Amyris, Inc. (US) | 2013-11-21 | — | — | US | disclosed |
| US-20130310615-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | Amyris, Inc. (US) | 2013-11-21 | — | — | US | disclosed |
| US-8519204-B2 | Stabilization methods for microbial-derived olefins | Amyris, Inc. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2414311-A2 | STABILIZATION AND HYDROGENATION METHODS FOR MICROBIAL-DERIVED OLEFINS | Amyris, Inc. (US) | 2012-02-08 | — | — | EP | disclosed |
| US-20100267971-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | EUAGORE, LLC | 2010-10-21 | — | — | US | disclosed |
| WO-2010115097-A2 | STABILIZATION AND HYDROGENATION METHODS FOR MICROBIAL-DERIVED OLEFINS | AMYRIS BIOTECHNOLOGIES, INC (US) | 2010-10-07 | — | — | WO | disclosed |
| JP-H07300593-A | ODORLESS LIQUID FUEL FOR OPEN FLAME OIL COOKER | IDEMITSU PETROCHEM CO LTD | 1995-11-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130310617-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | SPOUT1, HDHD5, HAO2 | LMNA 4691/4885BLM 1645/4885PTPN1 4688/4885 |
| US-20130310615-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | SPOUT1, HDHD5, HAO2 | LMNA 4691/4885BLM 1645/4885PTPN1 4688/4885 |
| US-20170283346-A1 | STABILIZATION AND HYDROGENATION METHODS FOR MICROBIAL-DERIVED OLEFINS | HPD, DUOX1, HAO2 | LMNA 4665/4885BLM 1751/4885PTPN1 4236/4885 |
| US-20100267971-A1 | Stabilization And Hydrogenation Methods For Microbial-Derived Olefins | SPOUT1, HDHD5, HAO2 | LMNA 4691/4885BLM 1645/4885PTPN1 4688/4885 |
| US-10894754-B2 | Stabilization and hydrogenation methods for microbial-derived olefins | SPOUT1, HDHD5, HAO2 | LMNA 4691/4885BLM 1645/4885PTPN1 4688/4885 |
| US-12441846-B2 | Elastomer with C—O—Si linkages between polyester backbone and crosslinker | ILK, SCO2, CCNO | LMNA 1700/4885BLM 378/4885PTPN1 4336/4885 |
| US-20250263521-A1 | ELASTOMER WITH C-O-Si LINKAGES BETWEEN POLYESTER BACKBONE AND CROSSLINKER | ILK, SMC4, SMC2 | LMNA 1593/4885BLM 257/4885PTPN1 4322/4885 |
| US-20250197341-A1 | METHOD FOR INHIBITING CRYSTALLISATION | FASN, SCD5, NFKB2 | LMNA 149/4885BLM 4294/4885PTPN1 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.